1 April 2024 false Taxfiler 2024.6 true 14728473 business:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 14728473 2024-03-31 14728473 2024-04-01 2025-03-31 14728473 business:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 14728473 business:FilletedAccounts 2024-04-01 2025-03-31 14728473 2025-03-31 14728473 business:Director1 2024-04-01 2025-03-31 14728473 business:RegisteredOffice 2024-04-01 2025-03-31 14728473 2024-03-31 14728473 core:WithinOneYear 2025-03-31 14728473 core:WithinOneYear 2024-03-31 14728473 core:ShareCapital core:PreviouslyStatedAmount 2025-03-31 14728473 core:ShareCapital core:PreviouslyStatedAmount 2024-03-31 14728473 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-03-31 14728473 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-03-31 14728473 core:PreviouslyStatedAmount 2025-03-31 14728473 core:PreviouslyStatedAmount 2024-03-31 14728473 business:SmallEntities 2024-04-01 2025-03-31 14728473 countries:EnglandWales 2024-04-01 2025-03-31 14728473 core:FurnitureFittings 2024-04-01 2025-03-31 14728473 core:FurnitureFittings 2024-03-31 14728473 core:FurnitureFittings 2025-03-31 14728473 business:OrdinaryShareClass1 2024-04-01 2025-03-31 14728473 business:OrdinaryShareClass1 2023-04-01 2024-03-31 14728473 2023-04-01 2024-03-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 14728473 (England and Wales)
Glowmedix Limited Filleted accounts for the year ended 31 March 2025
Glowmedix Limited Filleted accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Glowmedix Limited Company Information for the year ended 31 March 2025
Director
Rabia Gilani
Company Number
14728473 (England and Wales)
Registered Office
128 City Road London EC1V 2NX United Kingdom
Accountants
YP Finance Hawthorne House 17A Hawthorne Drive Leicester Leicestershire LE5 6DL
- 3 -
Glowmedix Limited Statement of financial position as at 31 March 2025
2025
2024
Notes
£
£
Fixed assets
Tangible assets
4
10,585
-
Current assets
Inventories
5
5,326
5,326
Debtors
6
3,136
-
Cash at bank and in hand
138
786
8,600
6,112
Creditors: amounts falling due within one year
7
(37,884)
(7,823)
Net current liabilities
(29,284)
(1,711)
Net liabilities
(18,699)
(1,711)
Capital and reserves
Called up share capital
8
2
2
Profit and loss account
(18,701)
(1,713)
Shareholders' funds
(18,699)
(1,711)
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 31 December 2025 and were signed on its behalf by
Rabia Gilani Director Company Registration No. 14728473
- 4 -
Glowmedix Limited Notes to the Accounts for the year ended 31 March 2025
1
Statutory information
Glowmedix Limited is a private company, limited by shares, registered in England and Wales, registration number 14728473. The registered office is 128 City Road, London, EC1V 2NX, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Inventories
Inventories have been valued at the lower of cost and estimated selling price less costs to complete and sell. In respect of work in progress and finished goods, cost includes a relevant proportion of overheads according to the stage of manufacturing/completion.
Deferred taxation
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
Going concern
The financial statements have been prepared on a going concern basis. Although the company’s net assets are negative, the directors consider it appropriate as the company is expected to meet its liabilities as they fall due.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
25% Straight Line
- 5 -
Glowmedix Limited Notes to the Accounts for the year ended 31 March 2025
4
Tangible fixed assets
Fixtures & fittings
£
Cost or valuation
At cost
At 1 April 2024
-
Additions
14,113
At 31 March 2025
14,113
Depreciation
Charge for the year
3,528
At 31 March 2025
3,528
Net book value
At 31 March 2025
10,585
5
Inventories
2025
2024
£
£
Finished goods
5,326
5,326
5,326
5,326
6
Debtors
2025
2024
£
£
Amounts falling due within one year
Amounts due from group undertakings etc.
3,136
-
7
Creditors: amounts falling due within one year
2025
2024
£
£
Loans from directors
37,524
7,463
Accruals
360
360
37,884
7,823
8
Share capital
2025
2024
£
£
Allotted, called up and fully paid:
2 Ordinary shares of £1 each
2
2
9
Average number of employees
During the year the average number of employees was 1 (2024: 1).
- 6 -